BUKWANG PHARMACEUTICAL IND CO.,LTD

R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.

003000 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 동작구 대방동1길 47, 서울특별시
Website:: https://www.bukwang.co.kr/en/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bukwang Pharmaceutical Co., Ltd. is an R&D-focused pharmaceutical company engaged in the development, manufacturing, and commercialization of therapeutic drugs. The company employs an 'open innovation' strategy, utilizing strategic investments, joint ventures, research collaborations, and acquisitions to expand its drug pipeline and enhance its global competitiveness. Its development pipeline targets a range of conditions, with a focus on central nervous system (CNS) disorders such as schizophrenia (Lurasidone) and Parkinson's disease (JM-010), as well as oncology (SOL-804 for prostate cancer), liver diseases, and metabolic disorders. Through continuous research and strategic partnerships, Bukwang aims to become a global pharmaceutical innovator.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BUKWANG PHARMACEUTICAL IND CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BUKWANG PHARMACEUTICAL IND CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BUKWANG PHARMACEUTICAL IND CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CellSeed Inc. Develops cell sheet products, culture equipment, and offers contract manufacturing services.	Japan	7776
CellSource Co.,Ltd. Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.	Japan	4880
Celltrion, Inc. A biopharma pioneer developing biosimilars and novel drugs for immunology and oncology.	South Korea	068270
Celon Pharma S.A. Researches, develops, and markets innovative drugs for oncology and neurology.	Poland	CLN
Cessatech A/S Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.	Denmark	CESSA
CG Invites Co., Ltd. Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.	South Korea	083790
CHA Vaccine Research Institute Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.	South Korea	261780
CHEIL BIO CO., LTD. Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.	South Korea	052670
Chemical Works of Gedeon Richter Plc Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.	Hungary	RICHT
ChoA Pharmaceutical Co., LTD. Global manufacturer of OTC medicines and health supplements distributed through pharmacies.	South Korea	034940